SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-22-002700
Filing Date
2022-11-10
Accepted
2022-11-10 13:29:51
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING sgbi-20220930.htm   iXBRL 10-Q 567384
2 CERTIFICATION sgbi_ex31z1.htm EX-31.1 7528
3 CERTIFICATION sgbi_ex31z2.htm EX-31.2 8006
4 CERTIFICATION sgbi_ex32z1.htm EX-32.1 4333
  Complete submission text file 0001096906-22-002700.txt   2572342

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgbi-20220930_cal.xml EX-101.CAL 27962
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgbi-20220930_def.xml EX-101.DEF 50281
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgbi-20220930_lab.xml EX-101.LAB 140595
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgbi-20220930_pre.xml EX-101.PRE 123664
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgbi-20220930.xsd EX-101.SCH 23469
45 EXTRACTED XBRL INSTANCE DOCUMENT sgbi-20220930_htm.xml XML 353181
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 221376251
SIC: 2834 Pharmaceutical Preparations